AACR Round-Up: Zentalis, Pieris, Hookipa And Eli Lilly

DNA Damage Response Inhibitors, Fusion Proteins And KRAS Inhibitors

 
• By John Davis
  
cancer cell
The complexities of cancer cells are gradually being unpicked • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category